ClinicalTrials.gg
Not yet recruitingNCT07408011HOURRAUpdated Oct 30, 2026

Interest of Cryotherapy in Reducing Pain During Radial Arterial Blood Sampling

A Phase 3 interventional study of Apllication of medical device ice pack and Apllication of cream in Chronic Respiratory Diseases, sponsored by University Hospital, Brest. Not yet recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by University Hospital, Brest · Phase 3, Interventional, and Treatment

How we know

Updated Oct 30, 2026Start date movedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
258
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Pain by University Hospital, Brest — 2 open to participants now, 2 under way, 1 of them phase 3. Pain · University Hospital, Brest.

Started
2026
the only one that year
Phase 3
2 of 11
1 open now
Registered
11th of 11
by date

Among the 11 studies in Pain by University Hospital, Brest, this one is the only one that started in 2026, is one of 2 in phase 3, and was the 11th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

2 of the 11 studies in Pain by University Hospital, Brest are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Pain by University Hospital, Brest, or all of them as a file.
02

Study summary

Arterial puncture for blood gas analysis is a diagnostic procedure used to assess arterial blood gases and monitor a patient's oxygenation status. It is widely regarded by nursing staff as one of the most painful routine procedures. Despite this, the use of local anesthesia prior to arterial puncture remains uncommon in clinical practice.

Several types of anesthetic agents and administration techniques have been evaluated, with mixed results regarding their effectiveness in reducing patient-reported pain. Studies comparing subcutaneous lidocaine injection or ethyl chloride spray to no analgesic intervention have shown that ethyl chloride does not significantly reduce pain. Moreover, the discomfort caused by lidocaine injection appears to be comparable to that of the arterial puncture itself, suggesting limited overall benefit from this approach.

Other investigations have similarly reported a lack of significant pain reduction with ethyl chloride spray, although some contradictory findings exist. Ultrasound-guided arterial puncture has been shown to improve success rates and shorten procedure duration; however, it does not appear to influence pain perception.

The impact of needle size on pain intensity has also been explored, with conflicting results. Some studies found no significant difference in pain when using different gauge needles, while others reported reduced pain with the use of finer needles, such as insulin needles, compared to standard arterial puncture needles.

Topical anesthetic creams combining lidocaine and prilocaine have been assessed in randomized, double-blind trials. These studies found no significant difference between anesthetic and placebo groups in terms of pain intensity or the proportion of painful procedures.

More recently, cryotherapy has been investigated as a non-pharmacological method to reduce pain prior to arterial puncture. Several randomized controlled trials using varying cryotherapy protocols have generally reported a significant reduction in pain compared to control groups, with longer application times appearing to enhance effectiveness.

However, these findings must be interpreted with caution due to methodological limitations. In some studies, sample size calculations were not justified, randomization procedures were poorly described, and reported pain levels were unusually high compared to those typically observed in European populations, raising concerns about external validity. In certain cases, although pain reduction was statistically significant, it did not reach the minimal clinically important difference, limiting its clinical relevance.

Conversely, other trials reported very low pain scores following cryotherapy, suggesting a substantial clinical benefit. The short application time required for cryotherapy also makes it far more practical than topical anesthetic creams, which require prolonged application. This practicality supports its use in both emergency and outpatient settings.

Some authors have noted that blinding is challenging when using cryotherapy and have suggested incorporating placebo interventions in future studies to improve methodological rigor.

Overall, systematic analyses indicate that cryotherapy appears to be a safe and potentially effective method for reducing pain during arterial puncture. Nevertheless, the existing evidence is limited by a high risk of bias, underscoring the need for further high-quality randomized controlled trials.

Conclusion: Given the promising but methodologically constrained evidence, there is a strong justification for conducting a rigorously designed, placebo-controlled randomized trial to accurately assess the effectiveness of cryotherapy in reducing pain associated with radial arterial puncture.

03

Conditions studied

  • Chronic Respiratory Diseases

Browse trials for

Keywords

  • Arterial blood gas
  • Pain
  • Cryotherapy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient with a respiratory condition requiring arterial blood gas sampling via radial puncture
  • Patients able to assess their pain using a numerical rating scale
  • Patients reporting a pain score of 0 on the numerical scale at the wrist prior to sampling
  • Patients with no or allergies to local anesthetics such as lidocaine/prilocaine
  • Patients aged 18 years or older
  • Patients affiliated with or benefiting from a social security scheme
  • Patients able to give consent and who have signed an form

Exclusion criteria

Exclusion Criteria:

  • Patients reporting a pain score >0 on the numerical rating scale before sampling
  • Emergency context requiring immediate arterial blood gas results
  • Patients for whom radial arterial puncture is not feasible
  • Known to local amide-type anesthetics or any component of the lidocaine/prilocaine cream
  • Pregnant or breastfeeding women
  • Refusal to participate
  • Patients under legal guardianship or conservatorship
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
258 participants (estimated)

Study arms

  • Experimental
    Cryotherapy

    Application of a medical ice pack on the arm prior to the arterial blood gas procedure

    Device: Apllication of medical device ice pack

  • Placebo comparator
    Placebo cream

    Application of placebo cream on the arm prior the arterial blood gas procedure

    Drug: Apllication of cream

  • Active comparator
    Anesthetic cream

    Application of lidocaine cream on the arm prior arterial blood gas procedure

    Drug: Apllication of cream

Interventions

  • DeviceApllication of medical device ice pack

    Application of a medical device pack during 3 minutes on the area where the arterial blood gas will be performed.

  • DrugApllication of cream

    Application of a cream 120 min before on the area where the arterial blood gas will be performed.

06

What researchers measure

Primary outcomes

  1. Pain, measured on a 0-10 numerical rating scale

    The Pain experienced during the arterial puncture will be measured with the 0-10 numerical rating scale ( : 0 = no pain, and 10 = the worse pain)

    Time frame: Periprocedural

Secondary outcomes

  1. Situational anxiety, measured with the STAI-Y state scale

    The situational anxiety experienced just before the arterial puncture (i.e. 3 minutes after cryotherapy or 2 hours after cream application) will be measured with the STAI-Y state scale (ranging from 20 to 80, with higher score correlating with greater anxiety)

    Time frame: 3 minutes after cryotherapy or 2 hours after cream application]

  2. Situational anxiety measured by the heart rate

    The situational anxiety experienced just before the arterial puncture (i.e. 3 minutes after cryotherapy or 2 hours after cream application) will be measured by the heart rate in beat per minute with a pulse oxymeter

    Time frame: 3 minutes after cryotherapy or 2 hours after cream application

  3. Situational anxiety measured by the heart rate

    The situational anxiety experienced during the arterial puncture will be measured by the heart rate in beat per minute with a pulse oxymeter

    Time frame: Periprocedural

  4. Situational anxiety measured by the heart rate

    The situational anxiety experienced at the end of the arterial puncture will be measured by the heart rate in beat per minute with a pulse oxymeter

    Time frame: 1-minute postprocedural

  5. Success of the arterial puncture

    The arterial puncture will be measured as a success if the blood sample will be succeeded or as a failure : if the blood sample will be failed

    Time frame: 1-minute postprocedural

  6. Baseline anxiety measured with the HAD scale

    The baseline anxiety will be measured at inclusion with the HAD scale (ranging from 0 to 21 points, with higher score correlating with more severe symptoms)

    Time frame: Baseline

  7. Time taken to perform the arterial puncture

    the time of the blood sample will be noted

    Time frame: Start and end time of the arterial puncture

  8. Patient satisfaction or perception of the arterial puncture measured with a likert scale

    The satisfaction will be assessed after the end of arterial puncture with a likert scale ("Are you satisfied with the care you received during the arterial puncture?: Strongly agree, Agree, Neither agree nor disagree, Disagree, Strongly disagree)

    Time frame: 3-hour postprocedural

  9. Situational anxiety measured by the heart rate

    The situational anxiety experienced at the end of the arterial puncture will be measured by the heart rate in beat per minute with a pulse oxymeter

    Time frame: Postprocedural

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2028, 24 months later.

Of 111 non-industry phase 3 interventional studies under Pain, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 24 months is below that.

Counting every sponsor, half of 216 studies reached it within 18 months; a quarter within 9 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: start Feb 2026 → Nov 2026, primary completion Feb 2026 → Nov 2028 and completion Nov 2029 → Nov 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2026
First posted
Feb 12, 2026
StartEst.
Nov 1, 2026was Feb 2026
Primary completionEst.
Nov 1, 2028was Feb 2026
CompletionEst.
Nov 1, 2028was Nov 2029
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Feb 1, 2026→Nov 1, 2026
Oct 30, 2026
Primary completion
Feb 1, 2026→Nov 1, 2028
Oct 30, 2026
Study completion
Nov 1, 2029→Nov 1, 2028
Oct 30, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedpainPain, measured on a 0-10 numerical rating scaleTime frame: At inclusion → Periprocedural
Oct 30, 2026
Secondary outcomes
1 edited, 1 time frame changed, 7 added, 6 removed
What changed in the outcomes
  • EditedCompare patientPatient satisfaction or perception of the procedure between groupsarterial puncture measured with a likert scaleTime frame: end of procedure → 3-hour postprocedural
  • AddedSituational anxiety, measured with the STAI-Y state scaleTime frame: 3 minutes after cryotherapy or 2 hours after cream application]
  • AddedSituational anxiety measured by the heart rateTime frame: 3 minutes after cryotherapy or 2 hours after cream application
  • AddedSituational anxiety measured by the heart rateTime frame: Periprocedural
  • AddedSituational anxiety measured by the heart rateTime frame: 1-minute postprocedural
  • AddedSuccess of the arterial punctureTime frame: 1-minute postprocedural
  • AddedBaseline anxiety measured with the HAD scaleTime frame: Baseline
  • AddedSituational anxiety measured by the heart rateTime frame: Postprocedural
  • Removedthe pain , measured with the 0-10 numerical rating scale experienced during the puncture (between the use of a cream combining two local anesthetics (lidocaine/prilocaine) and a placebo cream)Time frame: At inclusion
  • RemovedCompare heart rate before the procedure between groupsTime frame: Before Procedure
  • RemovedCompare heart rate during the procedure between groupsTime frame: during Procedure
  • RemovedCompare heart rate after the procedure between groupsTime frame: after Procedure
  • RemovedCompare the success rate of the blood samples between groupsTime frame: after procedure
  • RemovedEvaluate the impact of anxiety on the pain experienced just before the procedureTime frame: just before procedure
  • Time frameTime taken to perform the arterial puncturestart and end time of the arterial puncture → Start and end time of the arterial puncture
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Start date Feb 1, 2026→Nov 1, 2026
    Primary completion Feb 1, 2026→Nov 1, 2028
    Study completion Nov 1, 2029→Nov 1, 2028
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedpainPain, measured on a 0-10 numerical rating scaleTime frame: At inclusion → Periprocedural
    Secondary outcomes 1 edited, 1 time frame changed, 7 added, 6 removed
    What changed in the outcomes
    • EditedCompare patientPatient satisfaction or perception of the procedure between groupsarterial puncture measured with a likert scaleTime frame: end of procedure → 3-hour postprocedural
    • AddedSituational anxiety, measured with the STAI-Y state scaleTime frame: 3 minutes after cryotherapy or 2 hours after cream application]
    • AddedSituational anxiety measured by the heart rateTime frame: 3 minutes after cryotherapy or 2 hours after cream application
    • AddedSituational anxiety measured by the heart rateTime frame: Periprocedural
    • AddedSituational anxiety measured by the heart rateTime frame: 1-minute postprocedural
    • AddedSuccess of the arterial punctureTime frame: 1-minute postprocedural
    • AddedBaseline anxiety measured with the HAD scaleTime frame: Baseline
    • AddedSituational anxiety measured by the heart rateTime frame: Postprocedural
    • Removedthe pain , measured with the 0-10 numerical rating scale experienced during the puncture (between the use of a cream combining two local anesthetics (lidocaine/prilocaine) and a placebo cream)Time frame: At inclusion
    • RemovedCompare heart rate before the procedure between groupsTime frame: Before Procedure
    • RemovedCompare heart rate during the procedure between groupsTime frame: during Procedure
    • RemovedCompare heart rate after the procedure between groupsTime frame: after Procedure
    • RemovedCompare the success rate of the blood samples between groupsTime frame: after procedure
    • RemovedEvaluate the impact of anxiety on the pain experienced just before the procedureTime frame: just before procedure
    • Time frameTime taken to perform the arterial puncturestart and end time of the arterial puncture → Start and end time of the arterial puncture
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07408011
Responsible party
Sponsor
First posted
Feb 12, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 1, 2028 (estimated)
Completion
Nov 1, 2028 (estimated)
Last update
Oct 30, 2026

Study contacts

Marc Beaumont
Contact
mbeaumont@ch-morlaix.fr
+33 02 98 62 61 60 ext. 7750

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion